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Hypothermia is often used to treat out of hospital cardiac arrest (OHCA) patients who often 
simultaneously receive insulin for stress induced hyperglycaemia. Variations in response to 
insulin reflect dynamic changes in insulin sensitivity (SI), defined by the overall metabolic 
response to stress and therapy. Thus, tracking and forecasting this parameter is important to 
provide safe glycaemic control in highly dynamic patients. This study examines stochastic 
forecasting models of model-based SI variability in OHCA patients to assess the resulting 
potential impact of this therapy on glycaemic control quality and safety. A retrospective 
analysis of clinically validated model-based SI profiles identified using data from 240 post-
cardiac arrest patients (9988 hours) treated with hypothermia, shortly after admission in the 
Intensive Care Unit (ICU). Data were divided into three periods: 1) cool (T ≥ 35
o
C); 2) idle 
period of 2 hours as hypothermia was removed; and 3) warm (T ≥ 37
o
C). The stochastic 
model captured 60.7% and 90.2% of SI predictions within the (25th–75th) and (5th–95th) 
probability forecast intervals during cool period. Equally, it is also recorded 62.8% and 
92.1% of SI predictions respectively during the warm period. Maintaining the kernel density 
variance estimator to c = 1.0 yielded 60.7% and 90.2% for the cool period. Similarly, 
adjusting a variance estimator of c = 2.0 yields 60.4% and 90.1% for the warm period.  A 
cohort-specific stochastic model of SI provided a conservative forecast for the inter-quartile 
range and was relatively exact for the 90% range. Adjusting the variance estimator provides a 
more accurate, cohort-specific stochastic model of SI dynamics for the 90% range. These 
latter results show clearly different levels and distribution of forecasted SI variability between 








Hyperglycaemia is  prevalent  in  critical  care (Capes et al. 2000; McCowen, Malhotra et al. 
2001; Mizock 2001; van den Berghe et al. 2001) and increases the  risks  of  further  
complications  and  mortality (Capes et al. 2000; van den Berghe et al. 2001; Krinsley 2003). 
Glycaemic control has shown benefits in reducing mortality (van den Berghe et al. 2001; 
Krinsley 2004; Chase et al. 2008). However, due in parts to excessive metabolic variability 
(Chase et al. 2011), other studies have found it difficult to reproduce these results 
(Brunkhorst et al. 2008; Finfer et al. 2009; Preiser et al. 2009) . Out-of-Hospital Cardiac 
Arrest (OHCA) patients have low survival rates and often experience hyperglycaemia (Taylor 
et al. 1994; Neumar et al. 2008). However, cardiac patients are one group who have more 
consistently shown benefit from glycaemic control (GC), but can be highly insulin resistant 
and variable, particularly on the first day of stay (Pretty et al. 2012). 
 
Hypothermia is often used to treat OHCA patients (Neumar et al. 2008). In general, it leads to 
a lowering of metabolic rate that induces changes in energy metabolism. However, its impact 
on metabolism and insulin resistance in critical illness is unknown, although one of the 
adverse events associated with hypothermic therapy is a decrease in insulin sensitivity and 
insulin secretion (Hayashi 2009). However, this decrease may not be notable in a cohort that 
is already highly resistant and variable (Pretty et al. 2012). Hence, understanding metabolic 
evolution and variability would enable safer, more accurate GC in this cohort. 
 
Model-based glycaemic control methods using both insulin and/or nutrition modulation have 
been employed successfully in the control of hyperglycaemia. These methods allow the 
derivation of patient metabolic state, SI in this case, by using serial blood glucose (BG) 
 
 
measurements, and records of nutrition and insulin administration (Chase et al. 2007) . Once 
the current SI has been identified, prediction of future SI would allow predictions of outcome 
BG concentration for an intended clinical intervention (Lin et al. 2008). 
 
Variations in the SI parameter reflect the metabolic response to stress (McCowen et al. 2001) 
and drug therapy (Pretty et al. 2011). Thus, tracking and forecasting this parameter is 
important to provide safe glycaemic control in the highly dynamic Out-of-Hospital Cardiac 
Arrest (OHCA) patients, treated with hypothermia. Since stochastic modeling has shown its 
ability to quantify the probability of a future SI (Lin et al. 2008), the resulting distribution of 
BG concentrations that would result from a given intervention can be determined (Lin et al. 
2008; Le Compte et al. 2010; Evans et al. 2011; Fisk et al. 2012) . This information can be 
used to guide both insulin and/or nutrition interventions, which is the key to avoid unintended 
hypoglycaemia, improve overall glycaemic control, and identify periods of potential high 
glucose variability that may be indicative of unusual clinical events or cohorts (Thomas et al. 
2014) . 
 
This paper presents the adaptation of a stochastic model for SI prediction from adult critical 
care to the unique clinical and physiological case of OHCA patients, treated with 
hypothermia. The stochastic model presented is constructed by the distribution of insulin 
sensitivity variation using a 2-D kernel density method. Clinically validated, model-based 
insulin sensitivity (SI) (Chase et al. 2010; Evans et al. 2011) is used to provide more accurate 
measure of patient metabolic state and its stochastic model during cool and warm periods. 
Modifications to the initial kernel density estimation model are made to explore and optimize 
the relationship between the model and the underlying dataset, particularly for the clinically 
 
 
relevant 90% range that can be used to quantify and minimize the risks of hyper- or hypo- 


































MATERIAL AND METHODS 
 
 Patients and Data 
 
 A retrospective analysis of glycaemic control data from 240 OHCA patients (9988 
hours) treated with hypothermia, shortly after admission to the Intensive Care Unit (ICU) at 
Christchurch Hospital, New Zealand, Erasme Hospital, Belgium and Lausanne Hospital, 
Switzerland. Patients from Christchurch Hospital (20) were on the SPRINT glycaemic 
control protocol (Chase, Shaw et al. 2008), whereas the remaining 160 patients from Erasme 
(82) and Lausanne (78) Hospitals were on unpublished local glycaemic protocols. Blood 
glucose (BG) and temperature readings were taken 1-2 hourly along with all insulin and 
nutrition data. Data were divided into three periods: 1) cool (T ≤ 35
o
C); 2) transition period 
of 2 hours as hypothermia was removed; and 3) warm after (T ≥ 37
o
C). A maximum of 24 
hours and a minimum of 15 hours for each period (1 and 3) were considered, ensuring a 
balance of contiguous data between periods. Overall demographics are shown in Table 1. 
 




Total patients, number (n) 240 240 
Total treatment, hours (h) 4987 5001 
Blood Glucose (mmol/L) [IQR] 7.40 [6.20-9.70]  6.56 [5.61-7.78]  
Insulin Rate, rate (U/hr) [IQR] 3.37 [1.33-8.00]  3.51 [1.60-7.00]  
Glucose Rate, rate (g/hr) [IQR] 2.69 [1.04-5.26]  5.41 [2.71-8.11]  






 Therapeutic hypothermia 
 Therapeutic Hypothermia (TH) was applied following a standardized written protocol. 
All patients were treated with mild TH to 33 ± 1
o
C for up to 24 hours, irrespective of age, 
initial arrest rhythm and other physiological conditions. TH was started immediately after 
admission, and was induced with ice-cold packs and/or intravenous cold fluids. Body 
temperature was maintained at hypothermia using a surface cooling device with a 
computerized adjustment of patient temperature target. During this time, some short-acting 
drugs, such as midazolam (0.1mg/kg.hr), fentanyl (1.5µg/kg/hr) and vecuronium (0.1mg/kg 
boluses), were used to administer sedation, analgesia and control shivering. Rewarming was 
achieved passively, and sedation-analgesia was typically stopped when patient temperature 




 The Metabolic System Model 
 Model-based insulin sensitivity (SI) in this study is a patient-specific parameter 
describing the whole body effect of insulin. The analysis of patient-specific insulin sensitivity 
employs the ICING model (Lin et al. 2011) as a glucose-insulin system model developed and 
clinically validated in critical care glycaemic control and insulin sensitivity studies (Chase et 
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A summary of parameter values and descriptions, and exogenous input variables for the 
model are listed in Tables 2 and 3 respectively.   
 
Table 2: Parameter values and descriptions for the ICING model  
Parameter Value Unit Description 
pG 0.006 min
-1
 Non-insulin mediated glucose removal 
EGP 1.16 mmol/min Endogenous glucose production rate 
CNS 0.3 mmol/min Central nervous system glucose uptake 
VG 13.3 L Plasma glucose distribution volume 
VI 4.0 L Plasma and interstitial insulin distribution 
volume 
αG 0.0154 L/mU Insulin binding saturation parameter 
αI 0.0017 L/mU Hepatic insulin clearance saturation 
parameter 
nI 0.006 min
-1 Trans-endothelial diffusion rate 
nC 0.006 min
-1 Interstitial insulin degradation rate 
nK 0.0542 min
-1 Renal insulin clearance rate 
nL 0.1578 min
-1 Hepatic insulin clearance rate 




 Glucose transport rate from stomach to gut 
d2 0.0069 min
-1
 Glucose transport rate from gut to plasma 
Pmax 6.11 mmol/min Maximum glucose flux from gut to plasma 
umin 16.7 mU/min Minimum pancreatic secretion rate 
umax 266.7 mU/min Maximum pancreatic secretion rate 
k1 ND 14.9 mU.L/mmol.min Pancreatic insulin secretion glucose-
sensitivity T2DM 4.9 
T1DM 0.0 






Table 3: Exogenous model input variables    
Variable Unit Description 
PN(t) mmol/min Intravenous glucose input rate (parenteral nutrition) 
D(t) mmol/min Oral glucose input rate (enteral nutrition) 
uex(t) mU/min Intravenous insulin input rate 
 
Insulin sensitivity SI is identified hourly from patient data, producing a step-wise hourly 
varying profile (Hann et al. 2005) . This profile effectively describes patient-specific 
metabolic behavior under time-varying physiologic conditions.  The validity and 
independence of this patient-specific parameter have been validated using data from 
independent, clinically matched cohorts (Chase et al. 2010) and in gold-standard insulin 
sensitivity tests (McAuley et al. 2011). 
 
 The Stochastic Model 
 A 2-D kernel density estimation method is used to construct the stochastic model that 
describes the hourly transition of SI. The kernel density method combines probability 
distribution functions for each point of data to generate an overall density function for the 
dataset. This method has the advantage of producing a smooth, physiologically likely, 
continuous function across the parameter range to provide continuity when interpolating SI 
forecasts to account for each particular patient state. It also automatically accounts for any 
possible multimodality where the density of data may show several distinct peaks 
corresponding to patterns of changes in SI. The overall result is a bivariate probability density 
function for the potential parameter values. The goal of this statistical model is to quantify the 
range of SI one hour ahead in time (SI,n+1) based on available data (SI, n , SI ,n − 1 , SI ,n − 2 , . . ., 
SI ,0) to guide real-time clinical control (Evans, Shaw et al. 2011; Fisk, Le Compte et al. 
2012). Thus, it is potentially important that the model is also as cohort-specific as possible for 




A 2-D kernel density method is chosen because the distribution of SI, n+1 varies with SI, n, and 
cannot be simply described with a single standard statistical distribution. Thus, the variations 
in SI can be treated as a Markov process. A Markov process has the property that the 
conditional probability density function of future states of the process, given the current state, 
depends only upon the current state. Therefore, using the Markov property of the stochastic 
behaviour of SI, the conditional probability density of SI ,n+1 taking on a value y can be 
calculated by knowing SI ,n = x. Model equations and derivation were defined in (Lin et al. 
2008)  . 
 
In this study, the model was cross validated by splitting the 240 of cool and warm patient 
cohorts into five groups, each containing 48 patients per period following the method of (Lin 
et al. 2008). For each group, the model created using the remaining 192 patients of the cohort 
representing approximately 3990 hours of data per period. Out-of-sample SI predictions were 
generated for the 48 patients of unused group and compared to the actual fitted SI from these 
48 patients to assess model accuracy and cohort generality. Based on results from in-sample 
tests, where the stochastic model is generated from the entire retrospective dataset and tested 
on the same data, and out-of-sample tests, where different subsets of data are used for model 
generation and testing, the kernel density estimator was modified by multiplying the variance 
estimators by a constant c (i.e., cσx and cσy) to explore the model bias-variance trade-off for 
this data between cool and warm periods as well as 6 and 12 hour blocks. This adjustment to 
the variance estimator effectively adjusts the kernel bandwidth and the degree of smoothing 






 Analyses and Metrics 
 
 Current SI (n) during the cool (T ≤ 35
o
C) and warm (T ≥ 37
o
C) periods were 
identified hourly using the ICING model (Lin et al. 2011) for each patient. Using current SI 
(n) data, the predicted SI (n+1) data can be generalized by shifting 1-hour forward from the 
current SI (n) data. These SI vectors will be paired and used to create the stochastic SI model 
of OHCA cohort. Stochastic SI models were analyzed during both cool and warm periods as 
follows: 
i)  Overall cohort patient. 
ii)  Analysis of patients in 6-hour block.  
Overall cohort analysis assessed the stochastic model behavior of insulin sensitivity during 
both cool and warm periods, which includes percentage of SI within prediction interval and 
analysis of modifying kernel density estimation. SI is also analyzed using 6-hour blocks, as 
described in Table 4, to capture SI variability and forecasting over time with different 
resolution. The analysis includes percentage of SI within predicted interval and analysis of 
modifying the kernel density estimation.  
 
Table 4: Descriptions of 6-hour blocks for data analysis 
Day 
6-hour blocks 
Block Hours Range Period 
1 
1 0 – 6 hours Cool 
2 6 – 12 hours Cool 
3 12 – 18 hours Cool 
4 18 – 24 hours Cool 
2 
5 24 – 30 hours Warm 
6 30 – 36 hours Warm 
7 36 – 42 hours Warm 





RESULTS AND DISCUSSIONS  
 
 Distribution of hourly variation in SI 
 
 Figure 1 presents the distribution of hourly variation in SI and the stochastic model 
percentile probability bands at c=1.0, for the 240 OHCA patients during cool (4987 hours) 
and warm (5001 hours) periods. Approximately 85% of the values during cool period, and 
70% during warm period are below 1.0 x 10
-3
 L/(mU.min). The results show that the hourly 
variation of SI is wider during the cool period, and SI  rises from cool to warm. 
 
Cool  Warm 
  
 
Fig. 1:   Probability interval and distribution of hourly variation in SI for OHCA patients, 
treated with hypothermia during cool (left) and warm (right) periods.   
 
 
Table 5 shows the in-sample results of stochastic model prediction widths for both cool (ncool 
= 4622 predictions) and warm (nwarm = 4832 predictions) periods. The number of predictions 
is less than the total hours of SI as the patient data records are not always perfectly divisible 




For the cool period, SI predictions (60.7%) were within the (25th–75th) probability intervals, 
and within the (5th–95th) probability interval. Thus, the proportion of SI values that fell 
within the forecast (25th–75th) probability intervals were measurably higher than the 
expected 50%, but very much closer for the 90%  intervals. Similar results could be observed 
for the warm period, but were measured higher than cool period for both 50% and 90% 
intervals. 
 

















 ] 90.2 % 92.1 % 
Data are presented as cohort median (ncool = 4622 predictions and nwarm = 4832 predictions) 
 
The percentage SI within prediction interval results of Lin et al. of 54.0% is within the (25th–
75th) probability bound shows that normal adult ICU patients with normal body temperature 
produce far closer to the ideal 50%. However, the prediction interval percentage results of 
60.7% and 62.8% at cool and warm respectively on the same probability bound for the 
OHCA patients, treated with hypothermia as shown in Table 5 appear to be unique and 
significant. These results are similar to neonates’ results of (Le Compte et al. 2010), which 









 Cross-Validation Comparison Studies 
 
 Table 6 shows the results of the cross validation comparison study for 240 patients’ 
cohort during the cool and warm periods, respectively. Generally, these results are consistent 
between groups, suggesting that the overall model contains sufficient data to account for the 
range of dynamics observed in this cohort.    
 




to create the 
model 
% SI within interval during 
cool period 





















1 [-,2,3,4,5] 60.1 90.5 64.1 92.3 
2 [1,-,3,4,5] 61.2 90.0 64.0 92.6 
3 [1,2,-,4,5] 61.9 90.8 61.7 91.8 
4 [1,2,3,-,5] 61.9 90.8 63.1 92.7 
5 [1,2,3,4,-] 62.6 90.7 63.8 92.8 
Overall [1,2,3,4,5] 60.7 90.2 62.8 92.1 
 
 Probability-bound determination using local variance estimator 
 
 Table 7 shows the effect of modifying the kernel density estimation for several values 
of c, ranging from 0.1 to 3.0. For this cohort, the increase of c > 1.0, yield better coverage 
widths for the expected proportions. Thus, for cool period, the value c=1.0 enables the best 
90% interval coverage, but is conservative for the inter-quartile range. Similarly, c= 2.0 is 





Table 7: Comparison of probability bounds for modifications of kernel density estimator (σ`x 
= cσx AND σ`y = cσy) during both cool and warm periods.  
 
C 
% of SI within probability bound 
during Cool period 
% of SI within probability bound 




















0.1 49.3 87.8 45.5 83.7 
0.2 50.2 88.4 48.2 84.4 
0.3 51.1 88.5 50.4 85.2 
0.5 53.5 88.6 52.2 85.9 
1.0 60.7 90.2 55.8 87.1 
1.5 66.2 91.3 58.0 88.9 
2.0 69.6 92.1 60.4 90.1 
2.5 72.2 92.7 62.8 91.2 
3.0 74.0 93.4 64.9 91.5 




The difference of optimal c values between cool and warm suggests that the variation and 
stochastic modeling for both periods are different, leading to potentially different control 
requirements to ensure safe glycaemic control in these highly dynamic patients and states. In 
particular, c=1.0 is currently used in the STAR protocol (Evans et al. 2012; Penning et al. 
2012)  in Medical ICU patients. Hence, no change is required for the cool period. However, 
during the warm period, the stochastic model requires a wider and smoother probability 
distribution coverage at c=2.0, which would necessitate a control change of this known 
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Fig. 2:    Probability-bound determination for raw SI data and corresponding BG forecasted 




 at local 
variance estimator, both cool ( c=1.0) and warm (c=2.0) period. The solid lines represent the 
5%, 25%, 50%, 75% and 95% probability bounds.    
 
 
The kernel density estimator method employed in this stochastic model provides a layer of 
safety as wider probability bounds would be more likely to capture dynamics and any 
changes not observed in the cohort. As the (5th - 95th) band is what has been used for control 
previously, these cohorts show that they are closer to ideal 90%. However, wider coverage 
bands may also have impact on glycaemic control performance. As the wider probability 
band might be useful to avoid potential hypoglycaemia, it may also force a controller to 
maintain a mildly hyperglycaemic state. Importantly, different level of smoothing are 
required for the cool and warm periods, indicating that cool patients are less multi-modal 
(more smoothed) and warm OHCA patients are more multi-modal (less smoothed), in 
comparison to broad ICU cohorts. Perhaps this scenario is caused by the suppression of 





 Stochastic Analysis by 6-hour block 
  
 The analysis of stochastic model based on 6-hour time block have used the same 
methodology as the overall cohort patient, except that the patient cohort data are separated in 
block hours. Table 8 presents the in-sample results of stochastic model prediction widths 
based on 6 hour block analysis at c=1.0. 
 






Block 1     
[0-6 hrs] 
Block 2        
[6-12 
hrs] 
Block 3     
[12-18 
hrs] 
Block 4     
[18-24 
hrs] 
Block 5     
[24-30 
hrs] 
Block 6     
[30-36 
hrs] 
Block 7     
[36-42 
hrs] 
Block 8    
[42-48 
hrs] 
% SI within 
prediction 
interval 
[25th – 75th ] 56.1 60.2 58.9 61.5 61.9 62.1 62.6 62.6 
[5th –  95th ] 90.1 91.9 91.0 91.3 91.2 92.2 92.3 92.7 
  
 
The results show that SI prediction interval coverage meets the prediction expectation despite 








) interval width 









) probability intervals for 6-hour block analysis were measured higher 
than the expected 50% and 90%.   
  
Table 9 shows the effect of modifying the kernel density estimation for several values of c, 
ranging from 0.1 to 3.0 based on 6 hour block analysis. For this cohort, the results has shown 
that for block 1, c=1.0 and followed by block 2 to block 3 (c=1.5), block 4 to block 5 (c=2.0), 
block 6 to block 7 (c=2.5), and block 8 (c=3.0). The trend shows that the value of estimator, c 
is increased as SI increases from cool to warm, and match with overall cohort stochastic 
 
 
model analysis as shown in the Table 7. This will lead to another idea of separating stochastic 
model for each time block to implement stochastic control. The difference of optimal c values 
between 6-hour blocks suggests that the variation and stochastic modeling for each time 
block is different, leading to different control requirements to ensure safe glycaemic control 
in the highly dynamic conditions.  
 
 







 Cool Period Warm Period 
% of SI within  
probability bounds 
at Block 1  
[0 – 6] hours 
% of SI within 
probability bounds 
at Block 2  
[6– 12] hours 
% of SI within  
probability bounds 
at Block 3  
[12 – 18] hours 
% of SI within  
probability bounds 
at Block 4  
[18 – 24] hours 
% of SI within  
probability bounds 
at Block 5  
[24 –  ] hours 
% of SI within  
probability bounds 
at Block 6  
[36 – 48] hours 
% of SI within  
probability bounds 
at Block 7  
[36 – 48] hours 
% of SI within  
probability bounds 
at Block 8  

































0.1 51.6 88.9 52.7 85.3 53.5 85.8 51.7 86.0 44.9 84.2 45.0 85.3 45.5 85.5 46.2 85.6 
0.2 51.4 89.3 53.5 86.2 54.3 86.6 52.1 86.2 45.3 84.5 45.4 85.8 46.2 85.8 46.7 85.9 
0.3 51.7 89.5 54.0 86.9 54.7 86.9 53.5 86.6 46.3 85.8 46.7 86.6 47.4 86.6 48.0 86.7 
0.5 53.1 89.6 55.6 88.8 55.1 87.8 54.3 87.4 48.4 86.5 48.6 87.0 49.2 87.1 49.3 87.3 
1.0 58.7 90.4 57.2 89.3 56.9 89.0 55.5 87.3 51.9 87.2 52.1 88.2 52.6 88.3 52.6 87.7 
1.5 62.7 91.0 58.9 90.7 58.0 90.6 57.2 88.2 54.9 87.8 55.2 88.6 55.5 88.8 55.7 88.3 
2.0 65.6 91.5 61.0 93.5 60.2 92.1 59.2 90.7 55.6 90.3 56.1 89.3 56.2 89.4 57.2 88.9 
2.5 67.3 92.3 63.4 94.2 62.7 92.5 60.8 92.4 56.2 91.9 55.8 90.9 57.3 90.1 58.5 89.5 
3.0 68.0 92.8 65.7 94.9 63.9 92.6 62.1 92.9 56.7 92.8 57.5 91.2 57.9 91.3 59.0 90.7 








Overall, this stochastic method and analysis in this study provides predictions based on a 
cohort dataset. The prediction bounds for more dynamic patients are difficult to decide since 
the SI level and variability distribution for this cohort is unique (Sah Pri et al. 2014), and 
tracked its evolution over time, particularly during cool period.  This observation is far 
differing than for the less dynamic patients who are typically more conservative. Thus, the 
probability bounds are optimized in a cohort sense, but not necessarily applicable on a per-
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